Clarus Therapeutics Holdings Stock Price, News & Analysis
Company Description
Clarus Therapeutics Holdings (OTC: CRXTQ) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $72.8K.
CRXTQ stock has declined 95.9% over the past year.
This page provides a comprehensive overview of CRXTQ stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Clarus Therapeutics Holdings (CRXTQ) stock. Over the past 12 months, the stock has lost 95.9%. At a market capitalization of $72.8K, CRXTQ is classified as a micro-cap stock with approximately 52.0M shares outstanding.
Latest News
Clarus Therapeutics Holdings has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition. View all CRXTQ news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CRXTQ Company Profile & Sector Positioning
Clarus Therapeutics Holdings (CRXTQ) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CRXTQ often look at related companies in the same sector, including LCI INDS (LCIN), (GENH), Nettec (NXTTF), (CANBD), and Nuvo Pharmaceuticals Inc (MRVFF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CRXTQ's relative position within its industry.